Literature DB >> 32243181

Tumor Microenvironment Stimuli-Responsive Nanoparticles for Programmed Anticancer Drug Delivery.

Nan Jia1, Wenpan Li1, Dan Liu1, Shiyang Wu1, Baohui Song1, Jizhuang Ma1, Dawei Chen1, Haiyang Hu1.   

Abstract

It is well-known that large size nanoparticles stay for a long time in the circulation system, but show poor tissue penetration and low cellular uptake. In order to reconcile the conflicting needs for extended circulation time, extensive tumor tissue penetration, and enhanced cellular uptake for nanodrug delivery systems, we designed DOX-containing hypersensitive nanoparticles that responded to the tumor microenvironment for programmed DOX delivery. A supersensitive polymer material, poly(2-ethyl-2-oxazoline)-poly(methacryloyl sulfadimethoxine), was synthesized (PEOz-b-PSD, pKa = 6.96). At the physiological environment, PEOz-b-PSD and polyamidoamine/DOX (PAMAM/DOX) can form nanoparticles, PEOz-b-PSD/PAMAM/DOX (PEPSD/PAM/DOX), via electrostatic adsorption. The PEPSD/PAM/DOX has an intact structure, which can prolong circulation time. While in the tumor environment, the PEOz-b-PSD was rapidly protonated and showed charge reversal, leading the detachment of PEOz-b-PSD from the nanoparticles; then the large size nanoparticles with a negative charge (PEPSD/PAM/DOX) instantaneously turn into positively charged ultrafine nanoparticles. The sudden inversion of size and charge can effectively improve tumor accumulation and internal penetration. After entering tumor cells, nanoparticles can release drugs quickly through the action of a PAMAM proton sponge, resulting in enhanced tumor inhibition. Our results proved that the programmed nanoparticles could remarkably enhance the in vivo antitumor efficacy and reduce cardiotoxicity of DOX. This study designed ultrasensitive nanoparticles in the tumor microenvironment, which appear to be beneficial for enhancing the treatment efficacy of DOX in solid tumors.

Entities:  

Keywords:  PAMAM dendrimers; charge-switchable; pH-sensitive nanoparticles; size-shrinkable; tumor infiltration

Mesh:

Substances:

Year:  2020        PMID: 32243181     DOI: 10.1021/acs.molpharmaceut.9b01189

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  5 in total

Review 1.  Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.

Authors:  Reju George Thomas; Suchithra Poilil Surendran; Yong Yeon Jeong
Journal:  Front Mol Biosci       Date:  2020-12-18

Review 2.  Charge reversal nano-systems for tumor therapy.

Authors:  Peng Zhang; Daoyuan Chen; Lin Li; Kaoxiang Sun
Journal:  J Nanobiotechnology       Date:  2022-01-10       Impact factor: 10.435

3.  Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity.

Authors:  Qiyi Feng; Junhuai Xu; Xinyi Liu; Haibo Wang; Junjie Xiong; Kai Xiao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

4.  pH and lipase-responsive nanocarrier-mediated dual drug delivery system to treat periodontitis in diabetic rats.

Authors:  Lu Wang; Yuzhou Li; Mingxing Ren; Xu Wang; Lingjie Li; Fengyi Liu; Yiqing Lan; Sheng Yang; Jinlin Song
Journal:  Bioact Mater       Date:  2022-02-17

5.  Temperature-Ion-pH Triple Responsive Gellan Gum as In Situ Hydrogel for Long-Acting Cancer Treatment.

Authors:  Shuwen Zhou; Xinmeng Zheng; Ke Yi; Xuancheng Du; Cheng Wang; Pengfei Cui; Pengju Jiang; Xinye Ni; Lin Qiu; Jianhao Wang
Journal:  Gels       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.